Last updated: August 19, 2024
Sponsor: Nova Scotia Health Authority
Overall Status: Active - Recruiting
Phase
N/A
Condition
Vascular Diseases
Treatment
Virtual PREHAB
Standard care
Clinical Study ID
NCT05617196
NS-NHIG-2021-1905
Ages 50-100 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Outpatients attending the TAVI clinic at the Queen Elizabeth II Health SciencesCentre
Informed written or verbal consent
Exclusion
Exclusion Criteria:
New York Heart Association or Canadian Cardiovascular Score of 4
Severe functional limitations
Cognitive impairment that impacts consenting ability
Significant language barrier
No internet or telephone access that precludes virtual PREHAB participation
Study Design
Total Participants: 40
Treatment Group(s): 2
Primary Treatment: Virtual PREHAB
Phase:
Study Start date:
January 05, 2023
Estimated Completion Date:
December 31, 2025
Connect with a study center
Nova Scotia Health
Halifax, Nova Scotia B4E 0H4
CanadaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.